Google has made a change to how it’s search results are served which will also help to secure it against bots and scrapers. Whether this will have further effect on SEO Tools or if they can use a ...

In a world-first trial, scientists used a one-off CRISPR gene edit to switch off a liver “fat brake” gene, slashing stubborn LDL cholesterol and triglycerides in patients whose levels refused to budge ...

Exhibited superior anti-tumor efficacy in a human lung cancer model in mice (HCC827 xenografts) compared to ivonescimab and an anti-VEGF-A antibody; Showed stronger anti-tumor activity against a human ...

KANSAS CITY, Kan., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company developing and advancing a pipeline of next-generation pharmaceutical products utilizing ...

Contineum Therapeutics has pumped the brakes on two projects, freeing up resources to go full speed ahead in its pursuit of Bristol Myers Squibb in idiopathic pulmonary fibrosis (IPF). The San ...

Community driven content discussing all aspects of software development from DevOps to design patterns. Note, this article deals with client-side JavaScript. For a client and server-side JavaScript ...

Cingulate Inc. submitted CTx-1301 Phase 3 safety data to the FDA, preparing for a Pre-NDA meeting on April 2, 2025. Cingulate Inc. announced the submission of Phase 3 safety data for its ADHD ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The drug was central to a $445 ...

A little less than two years after San Francisco’s Mirum Pharmaceuticals ponied up $210 million to acquire Travere Therapeutics’ bile acid portfolio, the deal has paid off with a fresh FDA approval.

Please provide your email address to receive an email when new articles are posted on . Mirum Pharmaceuticals received first treatment approval for treatment of cerebrotendinous xanthomatosis. Ctexli ...

In an exciting development for the cryptocurrency sector, Cryptex Finance (CTX) has experienced a significant surge in its ...